Ac Immune Stock Alpha and Beta Analysis

ACIU Stock  USD 3.40  0.01  0.29%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AC Immune. It also helps investors analyze the systematic and unsystematic risks associated with investing in AC Immune over a specified time horizon. Remember, high AC Immune's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AC Immune's market risk premium analysis include:
Beta
0.79
Alpha
0.11
Risk
3.61
Sharpe Ratio
0.0533
Expected Return
0.19
Please note that although AC Immune alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, AC Immune did 0.11  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of AC Immune stock's relative risk over its benchmark. AC Immune has a beta of 0.79  . As returns on the market increase, AC Immune's returns are expected to increase less than the market. However, during the bear market, the loss of holding AC Immune is expected to be smaller as well. At this time, AC Immune's Tangible Book Value Per Share is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 498.1 M in 2024, whereas Book Value Per Share is likely to drop 1.70 in 2024.

Enterprise Value

498.09 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out AC Immune Backtesting, AC Immune Valuation, AC Immune Correlation, AC Immune Hype Analysis, AC Immune Volatility, AC Immune History and analyze AC Immune Performance.
For more information on how to buy ACIU Stock please use our How to Invest in AC Immune guide.

AC Immune Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AC Immune market risk premium is the additional return an investor will receive from holding AC Immune long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AC Immune. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AC Immune's performance over market.
α0.11   β0.79

AC Immune expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AC Immune's Buy-and-hold return. Our buy-and-hold chart shows how AC Immune performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

AC Immune Market Price Analysis

Market price analysis indicators help investors to evaluate how AC Immune stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AC Immune shares will generate the highest return on investment. By understating and applying AC Immune stock market price indicators, traders can identify AC Immune position entry and exit signals to maximize returns.

AC Immune Return and Market Media

The median price of AC Immune for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 3.2 with a coefficient of variation of 7.27. The daily time series for the period is distributed with a sample standard deviation of 0.24, arithmetic mean of 3.26, and mean deviation of 0.19. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
AC Immune SA Welcomes New CMO Dr. Anke Post - TipRanks
09/19/2024
2
AC Immune NASDAQACIU investor three-year losses grow to 47 percent as the stock sheds US40m this past week
10/07/2024
3
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
11/05/2024
4
AC Immune stock jumps 20 percent on data for Parkinsons disease drug
11/14/2024
5
AC Immune stock jumps 20 percent on data for Parkinsons disease drug - MSN
11/20/2024

About AC Immune Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ACIU or other stocks. Alpha measures the amount that position in AC Immune has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2023 2024 (projected)
Days Sales Outstanding74.21371.04389.59
PTB Ratio1.462.222.11

AC Immune Upcoming Company Events

As portrayed in its financial statements, the presentation of AC Immune's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AC Immune's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AC Immune's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AC Immune. Please utilize our Beneish M Score to check the likelihood of AC Immune's management manipulating its earnings.
21st of March 2024
Upcoming Quarterly Report
View
26th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with AC Immune

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for ACIU Stock Analysis

When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.